Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Fundamentals
Mkt Cap
$4.16B
Volume
-
52W High
$30.74
52W Low
$12.00
PE Ratio
-64.94
Avg. Volume
2.25M
EPS (Annual)
-$0.3922
P/B
29.48
Rev/Employee
$443,871.80
Earnings
Nov 04
68
Bullish Sentiment
How do you feel about ADPT?
Treasury225
$ADPT no. Some holders should learn how to place a sell order on a small cap stock. Give away your own money and cause confusion. Dammit!